Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3010093011 | Sodium glucose cotransporter subtype 2 inhibitor (product) | en | Fully specified name | Inactive | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3010097012 | Sodium glucose cotransporter subtype 2 inhibitor | en | Synonym (core metadata concept) | Inactive | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3010102010 | SGLT2 inhibitor - Sodium glucose cotransporter subtype 2 inhibitor | en | Synonym (core metadata concept) | Inactive | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
| 3647492012 | Product containing sodium glucose cotransporter subtype 2 inhibitor (product) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3647493019 | Sodium glucose cotransporter subtype 2 inhibitor product | en | Synonym (core metadata concept) | Inactive | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3647494013 | SGLT2 inhibitor - Sodium glucose cotransporter subtype 2 inhibitor product | en | Synonym (core metadata concept) | Inactive | Entire term case sensitive (core metadata concept) | SNOMED CT core |
| 3647495014 | Product containing sodium glucose cotransporter subtype 2 inhibitor | en | Synonym (core metadata concept) | Inactive | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3746611019 | Sodium glucose cotransporter subtype 2 inhibitor-containing product | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing sodium glucose cotransporter subtype 2 inhibitor (product) | Is a | Product containing enzyme inhibitor (product) | false | Inferred relationship | Some | ||
| Product containing sodium glucose cotransporter subtype 2 inhibitor (product) | Is a | Medicinal product acting as antidiabetic agent (product) | false | Inferred relationship | Some | ||
| Product containing sodium glucose cotransporter subtype 2 inhibitor (product) | Has active ingredient | Sodium glucose cotransporter subtype 2 inhibitor | true | Inferred relationship | Some | 1 | |
| Product containing sodium glucose cotransporter subtype 2 inhibitor (product) | Is a | Medicinal product categorized by disposition (product) | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Product containing dapagliflozin (medicinal product) | Is a | True | Product containing sodium glucose cotransporter subtype 2 inhibitor (product) | Inferred relationship | Some | |
| Product containing canagliflozin (medicinal product) | Is a | True | Product containing sodium glucose cotransporter subtype 2 inhibitor (product) | Inferred relationship | Some | |
| Product containing empagliflozin (medicinal product) | Is a | True | Product containing sodium glucose cotransporter subtype 2 inhibitor (product) | Inferred relationship | Some | |
| Product containing ertugliflozin (medicinal product) | Is a | True | Product containing sodium glucose cotransporter subtype 2 inhibitor (product) | Inferred relationship | Some | |
| Product containing remogliflozin etabonate (medicinal product) | Is a | True | Product containing sodium glucose cotransporter subtype 2 inhibitor (product) | Inferred relationship | Some |
This concept is not in any reference sets
FHIR